{{Rsnum
|rsid=10943724
|Chromosome=6
|position=80593088
|Orientation=plus
|GMAF=0.3039
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 6.2 | 38.1 | 55.8
| HCB | 22.6 | 52.6 | 24.8
| JPT | 15.9 | 42.5 | 41.6
| YRI | 0.0 | 8.2 | 91.8
| ASW | 0.0 | 19.3 | 80.7
| CHB | 22.6 | 52.6 | 24.8
| CHD | 24.8 | 47.7 | 27.5
| GIH | 27.7 | 48.5 | 23.8
| LWK | 0.0 | 7.3 | 92.7
| MEX | 13.8 | 39.7 | 46.6
| MKK | 1.3 | 26.3 | 72.4
| TSI | 12.7 | 52.0 | 35.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=7E-6
  |OR=19.77
  |ORtxt=[11.15-28.39] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}